Sporadic Colorectal Cancer: An Infectious Disease?

Gastroenterology

Volumn 132, Issue 2, 2007, Pages 797-801

  Sinicrope, Frank A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DNA; PROSTAGLANDIN; PROSTAGLANDIN H2; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CANCER RISK; COLITIS; COLON ADENOMA; COLON CARCINOGENESIS; COLON FLORA; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DAMAGE; EDITORIAL; ENTEROCOCCUS FAECALIS; ENZYME INDUCTION; ENZYME INHIBITION; GAMMA IRRADIATION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MAMMAL CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECTUM ADENOMA;

EID: 33847077713     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.012     Document Type: Editorial

References (36)

1. Itzkowitz S.H., and Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G7-G17
2. Kado S., Uchida K., Funabashi H., Iwata S., Nagata Y., Ando M., Onoue M., Matsuoka Y., Ohwaki M., and Morotom I.M. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 61 (2001) 2395-2398
3. Engle S.J., Ormsby I., Pawlowski S., Boivin G.P., Croft J., Balish E., and Doetschman T. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 62 (2002) 6362-6366
4. Erdman S.E., Poutahidis T., Tomczak M., Rogers A.B., Cormier K., Plank B., Horwitz B.H., and Fox J.G. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162 (2003) 691-702
5. Newman J.V., Kosaka T., Sheppard B.J., Fox J.G., and Schauer D.B. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184 (2001) 227-230
6. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
7. Kim S.C., Tonkonogy S.L., Albright C.A., Tsang J., Balish E.J., Braun J., Huycke M.M., and Sartor R.B. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 (2005) 891-906
8. Balish E., and Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 169 (2002) 2253-2257
9. Erdman S.E., Rao V.P., Poutahidis T., Ihrig M.M., Ge Z., Feng Y., Tomczak M., Rogers A.B., Horwitz B.H., and Fox J.G. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 63 (2003) 6042-6050
10. Seril D.N., Liao J., Yang G.Y., and Yang C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24 (2003) 353-362
11. Risques R.A., Rabinovitch P.S., and Brentnall T.A. Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr Opin Gastroenterol 22 (2006) 382-390
12. Chu F.F., Esworthy R.S., Chu P.G., Longmate J.A., Huycke M.M., Wilczynski S., and Doroshow J.H. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 64 (2004) 962-968
13. Babbs C.F. Free radicals and the etiology of colon cancer. Free Radic Biol Med 8 (1990) 191-200
14. Erhardt J.G., Lim S.S., Bode J.C., and Bode C. A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human feces. J Nutr 127 (1997) 706-709
15. Huycke M.M., and Moore D.R. In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic Biol Med 33 (2002) 818-826
16. Huycke M.M., Abrams V., and Moore D.R. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23 (2002) 529-536
17. Wang X., and Huycke M.M. Extracellular superoxide production by enterococcus faecalis produces chromosomal instability in mammalian cells. Gastroenterology 132 (2007) 551-561
18. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
19. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., and Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993) 558-561
20. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., and Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
21. Cunningham J.M., Christensen E.R., Tester D.J., Kim C.Y., Roche P.C., Burgart L.J., and Thibodeau S.N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58 (1998) 3455-3460
22. Sinicrope F.A. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog 45 (2006) 447-454
23. Tardieu D., Jaeg J.P., Deloly A., Corpet D.E., Cadet J., and Petit C.R. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis 21 (2000) 973-976
24. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
25. Chapple K.S., Cartwright E.J., Hawcroft G., Tisbury A., Bonifer C., Scott N., Windsor A.C., Guillou P.J., Markham A.F., Coletta P.L., and Hull M.A. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156 (2000) 545-553
26. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., and Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
27. Kim H., Rhee S.H., Kokkotou E., Na X., Savidge T., Moyer M.P., Pothoulakis C., and LaMont J.T. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J Biol Chem 280 (2005) 21237-21245
28. Lee S.H., Williams M.V., Dubois R.N., and Blair I.A. Cyclooxygenase-2-mediated DNA damage. J Biol Chem 280 (2005) 28337-28346
29. Jurek D., Udilova N., Jozkowicz A., Nohl H., Marian B., and Schulte-Hermann R. Dietary lipid hydroperoxides induce expression of vascular endothelial growth factor (VEGF) in human colorectal tumor cells. FASEB J 19 (2005) 97-99
30. Nikolic D., and van Breemen R.B. DNA oxidation induced by cyclooxygenase-2. Chem Res Toxicol 14 (2001) 351-354
31. Sharma R.A., Gescher A., Plastaras J.P., Leuratti C., Singh R., Gallacher-Horley B., Offord E., Marnett L.J., Steward W.P., and Plummer S.M. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 22 (2001) 1557-1560
32. Winters M.D., Schlinke T.L., Joyce W.A., Glore S.R., and Huycke M.M. Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancer. Am J Gastroenterol 93 (1998) 2491-2500
33. Bardelli A., Cahill D.P., Lederer G., Speicher M.R., Kinzler K.W., Vogelstein B., and Lengauer C. Carcinogen-specific induction of genetic instability. Proc Natl Acad Sci U S A 98 (2001) 5770-5775
34. Rao C.V., Hirose Y., Indranie C., and Reddy B.S. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61 (2001) 1927-1933
35. Geier M.S., Butler R.N., and Howarth G.S. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. Cancer Biol Ther 5 (2006) 1265-1269
36. O'Mahony L., Feeney M., O'Halloran S., Murphy L., Kiely B., Fitzgibbon J., Lee G., O'Sullivan G., Shanahan F., and Collins J.K. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15 (2001) 1219-1225